Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

World News: . []

THE WOODLANDS Texas March 15 2019 GLOBE NEWSWIRE -- LINK  LXRX announced today dosing of the first LINK  in the otristat thyl for dvanced LINK  Tract ancer or TELE-ABC study which is a Phase 2a clinical study of telotristat ethyl in pati...

More news and information about Lexicon Pharmaceuticals, Inc.

Published By:

Globe Newswire: 14:39 GMT Friday 15th March 2019

Published: .

Search for other references to "lexicon" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us